In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study

The chemokine receptors CXCR1/2 play a key role in the aggressiveness of several types of cancers including head and neck squamous cell carcinomas (HNSCCs). In HNSCCs, CXCR1/2 signaling promotes cell proliferation and angiogenesis leading to tumor growth and metastasis. The competitive inhibitor of...

Descripción completa

Detalles Bibliográficos
Autores principales: Montemagno, Christopher, Serrano, Benjamin, Durivault, Jérôme, Nataf, Valérie, Mocquot, François, Amblard, Régis, Vial, Valérie, Ronco, Cyril, Benhida, Rachid, Dufies, Maeva, Faraggi, Marc, Pagès, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374394/
https://www.ncbi.nlm.nih.gov/pubmed/34430714
http://dx.doi.org/10.1016/j.bbrep.2021.101098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374394/
https://www.ncbi.nlm.nih.gov/pubmed/34430714
http://dx.doi.org/10.1016/j.bbrep.2021.101098

Ejemplares similares